Press Releases

Unedited news and product information from vendors.

Midas Medici Announces the Appointment of Mitch Lemons as New Vice President of Sales at Consonus
Jun 15, 2011 (05:06 PM EDT)


Customers to Benefit from Extensive Partner Knowledge and Strong Manufacturer Relations

NEW YORK, June 15, 2011 /PRNewswire/ -- Midas Medici Group Holdings, Inc. ("Midas") (OTCBB: MMED), an innovative green IT company in the fields of virtualization, cloud computing and data management, as well as Smart Grid solutions, today announced that its Consonus brand has named Mitch Lemons, a founder of Piedmont Technology Group, to head its Sales division as the new vice president of Sales. Formerly of Novell Corporation, Mr. Lemons has a strong reputation building, managing, and growing successful sales and business development teams that ultimately benefit customers and partners.

"Through our Consonus brand, Midas Medici is highly focused on addressing the increasing demand for green IT, cloud computing, virtualization and data management solutions," stated Nana Baffour, CEO and Co-Founder of Midas Medici.  "With his deep background and experience in the IT industry, Mitch Lemons is a tremendous asset to both Consonus and the broader Midas Medici group as a whole."

Bob McCarthy, President of Consonus commented, "We are thrilled to have someone of Mitch's caliber join our leadership team.  Mitch has spent his entire career developing high performing sales teams and helping customers solve business problems and IT challenges. He has a legacy of developing strong relationships with technology partners and will continue to do so at Consonus.  We look forward to the contributions he will make to our customers and our partners."

A technology industry veteran, Mr. Lemons has directed sales planning, process and program execution for notable companies like Novell, Courion, and Cimtec Automation.  Mr. Lemons served as president and co-founder of Piedmont Technology Group (PTG) where he grew the company and later sold PTG to Forsythe Solutions Group.

"Consonus affords me the opportunity to get back to my roots — working directly with partners and manufactures again," said Mitch Lemons. "I learned a great deal from working on the manufacturer side. I'll be able to utilize that specialized knowledge to make a significant impact with respect to both partners and customers."

An active member of the community, Mr. Lemons volunteers his time for numerous community service organizations and leading industry advisory councils.

About Midas Medici Group Holdings, Inc.

Midas Medici Group Holdings, Inc. (OTCBB: MMED) is a green IT company that supplies mid-sized and select enterprises and institutions with leading-edge IT solutions in the fields of virtualization, cloud computing and data management, as well as working with utilities and other institutions to transform the electric grid through digital technologies.  Across its Consonus and UtiliPoint brands, Midas works with its customers by optimizing IT and data center investments, cutting energy usage and preventing data loss, all while maximizing productivity.  Through a management team with decades of experience, Midas is positioning itself to take advantage of the high-growth IT industry through its unique specialized services at the intersection of energy and technology.  

For comprehensive investor relations material, including fact sheets, presentations conference calls and video, please follow the appropriate link: Investor Presentation, Investor Portal and Overview Video.

For more information on Midas Medici, please visit: www.midasmedici.com.

Safe Harbor Statement

This release contains certain "forward-looking statements" relating to the business of the Company and its subsidiary companies. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements regarding: the Company's business and operations; business strategy, plans and objectives of the Company and its subsidiaries; and any other statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

Company Contact:

Johnson Kachidza
Chief Financial Officer
212-792-0920

Investor Contact:

Trilogy Capital Partners
Darren Minton, President
Toll-free: 800-592-6067
info@trilogy-capital.com

SOURCE Midas Medici Group Holdings, Inc.